. 2023 Apr 26;43(2 Suppl 1):S28–S33. doi: 10.14639/0392-100X-suppl.1-43-2023-03

Table II.

Comparison of complaints and complications in HHT patients who asked to permanently remove the septal nasal splints vs those who maintained the splint in place.

	N (%)	VAS-C	P	VAS-P	P	VAS-O	P	VAS-Cr	P
Patients requiring permanent removal of the splints	11 (29.72)	6.36	P = 0.44	1.73	P = 0.51	4.36	P = 0.50	4.09	P = 0.25
Patients maintaining splints in place	26 (70.28)	5.46	P = 0.44	1.23	P = 0.51	3.65	P = 0.50	5.30	P = 0.25

HHT: Hereditary haemorrhagic telangiectasia; VAS-C: visual analogue scale for cacosmia; VAS-P: visual analogue scale for pain; VAS-O: visual analogue scale for obstruction; VAS-Cr: visual analogue scale for crusting.